ID

35267

Description

ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02517515

Link

https://clinicaltrials.gov/show/NCT02517515

Keywords

Versions (1)
  1. 2/25/19 2/25/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

February 25, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Hepatitis C Virus NCT02517515

English

Eligibility Chronic Hepatitis C Virus NCT02517515

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. chinese, south korean, and taiwanese descent with full chinese, south korean, and taiwanese parentage
Description

Chinese | Born in South Korea | Taiwanese

Data type

boolean

Alias
UMLS CUI [1]
C0152035
UMLS CUI [2]
C1277434
UMLS CUI [3]
C1556096
2. chronic hcv-infection prior to study enrollment.
Description

Hepatitis C, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0524910
3. screening laboratory result indicating hcv gt 1b infection.
Description

Hepatitis C Genotype

Data type

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C0017431
4. per local standard practice, documented results of one of the following:
Description

Result

Data type

boolean

Alias
UMLS CUI [1]
C1274040
liver biopsy within 24 months prior to or during screening demonstrating the absence of cirrhosis, e.g., a metavir score of ≤ 3 or an ishak score of ≤ 4; or
Description

Liver Cirrhosis Absent Biopsy of liver | Metavir score f4 | Ishak Score

Data type

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0193388
UMLS CUI [2]
C4481041
UMLS CUI [3]
C2986945
a screening fibrotest score of ≤ 0.72 and aspartate aminotransferase to platelet ratio index (apri) ≤ 2; or
Description

FibroTest Score Measurement | AST to platelet ratio index

Data type

boolean

Alias
UMLS CUI [1]
C3642160
UMLS CUI [2]
C4483916
a screening fibroscan result of < 9.6 kpa. (participants with a non-qualifying fibrotest/apri or fibroscan result may only be enrolled if they have a qualifying liver biopsy performed within 24 months prior to or during screening.)
Description

Fibroscan

Data type

boolean

Alias
UMLS CUI [1]
C4522043
5. participant has never received antiviral treatment (including ifn-based therapy [ifn (alpha, beta or pegifn) with or without rbv]) for hepatitis c infection (treatment-naïve participant) or participant must have documentation that they met the definition of one of the following categories (treatment experienced participant):
Description

Antiviral Therapy Absent Hepatitis C | Interferon Absent | Interferon-alpha Absent | Interferon-beta Absent | PEGINTERFERON Absent | Absence Interferon With Ribavirin

Data type

boolean

Alias
UMLS CUI [1,1]
C0280274
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0019196
UMLS CUI [2,1]
C3652465
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0002199
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0015980
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0982327
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0332197
UMLS CUI [6,2]
C3652465
UMLS CUI [6,3]
C0332287
UMLS CUI [6,4]
C0035525
non-responder or relapser
Description

Therapy non-responder | Recurrent disease

Data type

boolean

Alias
UMLS CUI [1]
C0919875
UMLS CUI [2]
C0277556
6. participant has plasma hcv rna level > 10,000 iu/ml at screening.
Description

Plasma Hepatitis C virus RNA Level

Data type

boolean

Alias
UMLS CUI [1,1]
C0032105
UMLS CUI [1,2]
C0369335
UMLS CUI [1,3]
C0441889
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. hcv genotype performed during screening indicating unable to genotype or infection with any other hcv genotype.
Description

Hepatitis C virus genotype determination

Data type

boolean

Alias
UMLS CUI [1]
C1533728
2. positive test result at screening for hepatitis b surface antigen (hbsag), or hbv-dna > lower limit of quantification (lloq) if hbsag negative, or anti-human immunodeficiency virus antibody (hiv ab).
Description

Hepatitis B surface antigen positive | Hbv DNA Test | HIV Antibody Measurement

Data type

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C1256114
UMLS CUI [3]
C3714540
3. any current or past clinical evidence of cirrhosis such as ascites or esophageal varices, or prior biopsy showing cirrhosis, e.g., a metavir score of > 3 or ishak score of > 4.
Description

Liver Cirrhosis | Ascites | Esophageal Varices | Liver Cirrhosis Biopsy Previous | Metavir score f4 | Ishak Score

Data type

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2]
C0003962
UMLS CUI [3]
C0014867
UMLS CUI [4,1]
C0023890
UMLS CUI [4,2]
C0005558
UMLS CUI [4,3]
C0205156
UMLS CUI [5]
C4481041
UMLS CUI [6]
C2986945
4. any primary cause of liver disease other than chronic hcv infection, including but not limited to the following:
Description

Cause Primary Liver disease | Exception Chronic Hepatitis C

Data type

boolean

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C0205225
UMLS CUI [1,3]
C0023895
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0524910
hemochromatosis
Description

Hemochromatosis

Data type

boolean

Alias
UMLS CUI [1]
C0018995
alpha-1 antitrypsin deficiency
Description

alpha 1-Antitrypsin Deficiency

Data type

boolean

Alias
UMLS CUI [1]
C0221757
wilson's disease
Description

Hepatolenticular Degeneration

Data type

boolean

Alias
UMLS CUI [1]
C0019202
autoimmune hepatitis
Description

Hepatitis, Autoimmune

Data type

boolean

Alias
UMLS CUI [1]
C0241910
alcoholic liver disease
Description

Alcoholic Liver Disease

Data type

boolean

Alias
UMLS CUI [1]
C0023896
drug-related liver disease steatosis and steatohepatitis on a liver biopsy coincident with hcv-related changes would not be considered exclusionary unless the steatohepatitis is considered to be the primary cause of the liver disease.
Description

Drug-Induced Liver Disease | Fatty degeneration | Steatohepatitis

Data type

boolean

Alias
UMLS CUI [1]
C0860207
UMLS CUI [2]
C0152254
UMLS CUI [3]
C2711227
5. screening laboratory analyses showing abnormal kidney, hepatic, or hematologic function.
Description

Abnormal renal function | Liver Dysfunction | Hematologic function Abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0151746
UMLS CUI [2]
C0086565
UMLS CUI [3,1]
C0221130
UMLS CUI [3,2]
C0205161
6. use of known strong inducers of cytochrome p450 3a (cyp3a) or strong inhibitors of cyp2c8 within 2 weeks or within 10 half-lives, whichever is longer, of the respective medication/supplement prior to study drug administration.
Description

CYP3A Inducers | CYP2C8 Inhibitors

Data type

boolean

Alias
UMLS CUI [1]
C3850044
UMLS CUI [2]
C3850061
Back to the top of the page

Similar models

Eligibility Chronic Hepatitis C Virus NCT02517515

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Chinese | Born in South Korea | Taiwanese
Item
1. chinese, south korean, and taiwanese descent with full chinese, south korean, and taiwanese parentage
boolean
C0152035 (UMLS CUI [1])
C1277434 (UMLS CUI [2])
C1556096 (UMLS CUI [3])
Hepatitis C, Chronic
Item
2. chronic hcv-infection prior to study enrollment.
boolean
C0524910 (UMLS CUI [1])
Hepatitis C Genotype
Item
3. screening laboratory result indicating hcv gt 1b infection.
boolean
C0019196 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
Result
Item
4. per local standard practice, documented results of one of the following:
boolean
C1274040 (UMLS CUI [1])
Liver Cirrhosis Absent Biopsy of liver | Metavir score f4 | Ishak Score
Item
liver biopsy within 24 months prior to or during screening demonstrating the absence of cirrhosis, e.g., a metavir score of ≤ 3 or an ishak score of ≤ 4; or
boolean
C0023890 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0193388 (UMLS CUI [1,3])
C4481041 (UMLS CUI [2])
C2986945 (UMLS CUI [3])
FibroTest Score Measurement | AST to platelet ratio index
Item
a screening fibrotest score of ≤ 0.72 and aspartate aminotransferase to platelet ratio index (apri) ≤ 2; or
boolean
C3642160 (UMLS CUI [1])
C4483916 (UMLS CUI [2])
Fibroscan
Item
a screening fibroscan result of < 9.6 kpa. (participants with a non-qualifying fibrotest/apri or fibroscan result may only be enrolled if they have a qualifying liver biopsy performed within 24 months prior to or during screening.)
boolean
C4522043 (UMLS CUI [1])
Antiviral Therapy Absent Hepatitis C | Interferon Absent | Interferon-alpha Absent | Interferon-beta Absent | PEGINTERFERON Absent | Absence Interferon With Ribavirin
Item
5. participant has never received antiviral treatment (including ifn-based therapy [ifn (alpha, beta or pegifn) with or without rbv]) for hepatitis c infection (treatment-naïve participant) or participant must have documentation that they met the definition of one of the following categories (treatment experienced participant):
boolean
C0280274 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
C3652465 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0002199 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0015980 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0982327 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0332197 (UMLS CUI [6,1])
C3652465 (UMLS CUI [6,2])
C0332287 (UMLS CUI [6,3])
C0035525 (UMLS CUI [6,4])
Therapy non-responder | Recurrent disease
Item
non-responder or relapser
boolean
C0919875 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
Plasma Hepatitis C virus RNA Level
Item
6. participant has plasma hcv rna level > 10,000 iu/ml at screening.
boolean
C0032105 (UMLS CUI [1,1])
C0369335 (UMLS CUI [1,2])
C0441889 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Hepatitis C virus genotype determination
Item
1. hcv genotype performed during screening indicating unable to genotype or infection with any other hcv genotype.
boolean
C1533728 (UMLS CUI [1])
Hepatitis B surface antigen positive | Hbv DNA Test | HIV Antibody Measurement
Item
2. positive test result at screening for hepatitis b surface antigen (hbsag), or hbv-dna > lower limit of quantification (lloq) if hbsag negative, or anti-human immunodeficiency virus antibody (hiv ab).
boolean
C0149709 (UMLS CUI [1])
C1256114 (UMLS CUI [2])
C3714540 (UMLS CUI [3])
Liver Cirrhosis | Ascites | Esophageal Varices | Liver Cirrhosis Biopsy Previous | Metavir score f4 | Ishak Score
Item
3. any current or past clinical evidence of cirrhosis such as ascites or esophageal varices, or prior biopsy showing cirrhosis, e.g., a metavir score of > 3 or ishak score of > 4.
boolean
C0023890 (UMLS CUI [1])
C0003962 (UMLS CUI [2])
C0014867 (UMLS CUI [3])
C0023890 (UMLS CUI [4,1])
C0005558 (UMLS CUI [4,2])
C0205156 (UMLS CUI [4,3])
C4481041 (UMLS CUI [5])
C2986945 (UMLS CUI [6])
Cause Primary Liver disease | Exception Chronic Hepatitis C
Item
4. any primary cause of liver disease other than chronic hcv infection, including but not limited to the following:
boolean
C0015127 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0023895 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0524910 (UMLS CUI [2,2])
Hemochromatosis
Item
hemochromatosis
boolean
C0018995 (UMLS CUI [1])
alpha 1-Antitrypsin Deficiency
Item
alpha-1 antitrypsin deficiency
boolean
C0221757 (UMLS CUI [1])
Hepatolenticular Degeneration
Item
wilson's disease
boolean
C0019202 (UMLS CUI [1])
Hepatitis, Autoimmune
Item
autoimmune hepatitis
boolean
C0241910 (UMLS CUI [1])
Alcoholic Liver Disease
Item
alcoholic liver disease
boolean
C0023896 (UMLS CUI [1])
Drug-Induced Liver Disease | Fatty degeneration | Steatohepatitis
Item
drug-related liver disease steatosis and steatohepatitis on a liver biopsy coincident with hcv-related changes would not be considered exclusionary unless the steatohepatitis is considered to be the primary cause of the liver disease.
boolean
C0860207 (UMLS CUI [1])
C0152254 (UMLS CUI [2])
C2711227 (UMLS CUI [3])
Abnormal renal function | Liver Dysfunction | Hematologic function Abnormal
Item
5. screening laboratory analyses showing abnormal kidney, hepatic, or hematologic function.
boolean
C0151746 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
C0221130 (UMLS CUI [3,1])
C0205161 (UMLS CUI [3,2])
CYP3A Inducers | CYP2C8 Inhibitors
Item
6. use of known strong inducers of cytochrome p450 3a (cyp3a) or strong inhibitors of cyp2c8 within 2 weeks or within 10 half-lives, whichever is longer, of the respective medication/supplement prior to study drug administration.
boolean
C3850044 (UMLS CUI [1])
C3850061 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial